全文获取类型
收费全文 | 28361篇 |
免费 | 1123篇 |
国内免费 | 1552篇 |
专业分类
耳鼻咽喉 | 334篇 |
儿科学 | 656篇 |
妇产科学 | 799篇 |
基础医学 | 3892篇 |
口腔科学 | 411篇 |
临床医学 | 2307篇 |
内科学 | 5400篇 |
皮肤病学 | 272篇 |
神经病学 | 1640篇 |
特种医学 | 629篇 |
外国民族医学 | 3篇 |
外科学 | 3251篇 |
综合类 | 2671篇 |
现状与发展 | 23篇 |
一般理论 | 16篇 |
预防医学 | 1381篇 |
眼科学 | 934篇 |
药学 | 2788篇 |
5篇 | |
中国医学 | 643篇 |
肿瘤学 | 2981篇 |
出版年
2024年 | 60篇 |
2023年 | 202篇 |
2022年 | 166篇 |
2021年 | 130篇 |
2020年 | 111篇 |
2019年 | 79篇 |
2018年 | 89篇 |
2017年 | 56篇 |
2016年 | 44篇 |
2015年 | 104篇 |
2014年 | 296篇 |
2013年 | 98篇 |
2012年 | 4295篇 |
2011年 | 4735篇 |
2010年 | 788篇 |
2009年 | 401篇 |
2008年 | 2814篇 |
2007年 | 2952篇 |
2006年 | 2658篇 |
2005年 | 2482篇 |
2004年 | 2117篇 |
2003年 | 1749篇 |
2002年 | 1446篇 |
2001年 | 819篇 |
2000年 | 1093篇 |
1999年 | 509篇 |
1998年 | 182篇 |
1997年 | 118篇 |
1996年 | 52篇 |
1995年 | 52篇 |
1994年 | 37篇 |
1993年 | 29篇 |
1992年 | 42篇 |
1991年 | 22篇 |
1990年 | 19篇 |
1989年 | 25篇 |
1988年 | 23篇 |
1987年 | 18篇 |
1986年 | 14篇 |
1985年 | 16篇 |
1984年 | 16篇 |
1983年 | 12篇 |
1982年 | 11篇 |
1981年 | 18篇 |
1980年 | 12篇 |
1979年 | 12篇 |
1978年 | 2篇 |
1959年 | 4篇 |
1944年 | 1篇 |
1930年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Zeyu Li Erwei Hao Rui Cao Si Lin Linghui Zou Tianyan Huang Zhengcai Du Xiaotao Hou Jiagang Deng 《中草药(英文版)》2022,14(4):479-493
Zedoary tumeric (Curcumae Rhizoma, Ezhu in Chinese) has a long history of application and has great potential in the treatment of liver cancer. The anti liver cancer effect of zedoary tumeric depends on the combined action of multiple pharmacodynamic substances. In order to clarify the specific mechanism of zedoary tumeric against liver cancer, this paper first analyzes the mechanism of its single pharmacodynamic substance against liver cancer, and then verifies the joint anti liver cancer mechanism of its "pharmacodynamic group". By searching the research on the anti hepatoma effect of active components of zedoary tumeric in recent years, we found that pharmacodynamic substances, including curcumol, zedoarondiol, curcumenol, curzerenone, curdione, curcumin, germacrone, β-elemene, can act on multi-target and multi-channel to play an anti hepatoma role. For example, curcumin can regulate miR, GLO1, CD133, VEGF, YAP, LIN28B, GPR81, HCAR-1, P53 and PI3K/Akt/mTOR, HSP70/TLR4 and NF-κB. Wnt/TGF/EMT, Nrf2/Keap1, JAK/STAT and other pathways play an anti hepatoma role. Network pharmacological analysis showed that the core targets of the "pharmacodynamic group" for anti-life cancer are AKT1, EGFR, MAPK8, etc, and the core pathways are neuroactive live receiver interaction, nitrogen metabolism, HIF-1 signaling pathway, etc. At the same time, by comparing and analyzing the relationship between the specific mechanisms of pharmacodynamic substance and "pharmacodynamic group", it is found that they have great reference significance in target, pathway, biological function, determination of core pharmacodynamic components, formation of core target protein interaction, in-depth research of single pharmacodynamic substance, increasing curative effect and so on. By analyzing the internal mechanism of zedoary tumeric pharmacodynamic substance and "pharmacodynamic group" in the treatment of liver cancer, this paper intends to provide some ideas and references for the deeper pharmacological research of zedoary tumeric and the relationship between pharmacodynamic substance and "pharmacodynamic group". 相似文献
2.
的 了解血流感染肺炎克雷伯菌中CRISPR-Cas系统的分布特征并分析其与毒力基因和耐药的关系。方法 收集非重复血流感染肺炎克雷伯菌248株,使用Vitek2-Compact全自动微生物分析系统进行菌株鉴定及药物敏感性分析,PCR检测CRISPR-Cas系统3个相关基因(CRISPR1、CRISPR2和cas1)、筛查6种常见高毒力荚膜血清型(K1、K2、K5、 K20、K54和K57)、12种毒力基因及检测13种耐药基因,用χ2检验比较携带有CRISPR-Cas系统菌株与不携带CRISPR-Cas系统菌株毒力及耐药差异。结果 CRISPR-Cas系统的检出率为29.8%(74/248);K1型是携带CRISPR-Cas系统肺炎克雷伯菌的主要荚膜血清型,占 28.4%(21/74);除kpn基因外,携带CRISPR-Cas系统菌株的毒力基因检出率均大于不携带CRISPR-Cas系统菌株,其中7种差异有统计学意义;除对氨苄西林耐药率达100%外,携带有CRISPR-Cas系统菌株的其他抗菌药物耐药率均小于不携带有CRISPR-Cas系统菌株,其中13种差异有统计学意义;携带CRISPR-Cas系统菌株的耐药基因阳性率小于不携带CRISPR-Cas系统的菌株,且blaKPC、blaSHV、qnrS基因差异有统计学意义。结论 高毒力荚膜血清型肺炎克雷伯菌中主要为K1型携带CRISPR-Cas系统,携带CRISPR-Cas系统的肺炎克雷伯菌相对于不携带CRISPR-Cas系统菌株的毒力基因阳性率高,耐药率低,耐药基因的阳性率低。CRISPR-Cas系统可能能降低耐药基因在肺炎克雷伯菌中的水平传播,尤其是在K1型肺炎克雷伯菌。 相似文献
3.
Abnormal accumulation ofα-synuclein contributes to the formation of Lewy bodies in the substantia nigra,which is considered the typical pathological hallmark of Parkinson's disease.Recent research indicates that angiotensin-(1-7)plays a crucial role in several neurodegenerative disorders,including Parkinson's disease,but the underlying mechanisms remain elusive.In this study,we used intraperitoneal administration of rotenone to male Sprague-Dawley rats for 4 weeks to establish a Parkinson's disease model.We investigated whether angiotensin-(1-7)is neuroprotective in this model by continuous administration of angiotensin-(1-7)into the right substantia nigra for 4 weeks.We found that angiotensin-(1-7)infusion relieved characteristic parkinsonian behaviors and reducedα-synuclein aggregation in the substantia nigra.Primary dopaminergic neurons were extracted from newborn Sprague-Dawley rat substantia nigras and treated with rotenone,angiotensin-(1-7),and/or the Mas receptor blocker A-779 for 24 hours.After binding to the Mas receptor,angiotensin-(1-7)attenuated apoptosis andα-synuclein aggregation in rotenone-treated cells.Primary dopaminergic neurons were also treated with angiotensin-(1-7)and/or the autophagy inhibitor 3-methyladenine for 24 hours.Angiotensin-(1-7)increasedα-synuclein removal and increased the autophagy of rotenone-treated cells.We conclude that angiotensin-(1-7)reducesα-synuclein aggregation by alleviating autophagy dysfunction in Parkinson's disease.Therefore,the angiotensin-(1-7)/Mas receptor axis plays an important role in the pathogenesis of Parkinson's disease and angiotensin-(1-7)has potential therapeutic value for Parkinson's disease.All experiments were approved by the Biological Research Ethics Committee of Nanjing First Hospital(approval No.DWSY-2000932)in January 2020. 相似文献
4.
目的:旨在评估子宫肌瘤栓塞(UFE)治疗的疗效并分析U FE治疗失败的相关因素。设计:回顾性研究。机构:大学教学医院。患者:233例1997年11月至2004年2月连续接受U FE治疗的患者。干预:3位介入放射学专家应用355-500-μ聚乙烯醇微粒实施了子宫肌瘤栓塞术。主要观察指标:子宫切除率、子宫肌瘤切除率及重复U FE治疗率。结果:患者平均随访时间为13个月。总计有22例(9.4%)患者在U FE治疗后又接受了手术治疗,其中16例(6.9%)行子宫切除术,6例(2.6%)行子宫肌瘤切除术,包括3例患者进行了重复的U FE治疗后仍需手术治疗。U FE与后继治疗的平均间… 相似文献
5.
背景:识别慢性乙型肝炎患者并发症发生的危险因素,对于治疗标准的制定非常重要。目的:确定亚洲慢性乙肝患者并发症发生的危险因素。患者与方法:对总共3233例中国慢性乙肝患者(平均随访46.8个月)的下列项目进行监测:肝脏组织活检、病毒血清学、乙肝病毒(H BV)DNA水平、病情急性恶化、乙肝e抗原(H BeAg)血清转化、发展为肝硬化相关并发症和肝细胞癌。结果:H BeAg血清转化及发展出现并发症的中位年龄分别为35岁和57.2岁。与血清谷丙转氨酶(ALT)水平<0.5倍正常上限值(ULN)的患者相比,血清ALT水平为ULN的0.5~1倍及1~2倍患者出现并发… 相似文献
6.
背景:接受化学药物治疗的乙型肝炎表面抗原(H BsAg)阳性患者,在停止预防性应用拉米夫定之后,其肝脏疾病的预后目前尚不清楚。目的:该研究旨在调查停止预防性应用拉米夫定之后,乙型肝炎病毒被再次激活的概率。方法:46例H BsAg阳性患者,在化疗开始前1周,预防性应用拉米夫定,并持续用药至整个化疗期间。预防性使用拉米夫定的中位停药时间为化疗结束后3.1个月(极差3.0~3.4个月)。停止预防性使用拉米夫定之后,对患者进行长期随访。结果:停止应用拉米夫定后的中位随访期为25.7个月(极差5.7~75.7个月)。11/46例(23.9%)在停止使用拉米夫定之后… 相似文献
7.
耳压治疗小儿抽动症57例 总被引:6,自引:0,他引:6
纪胜翔 《现代中西医结合杂志》2003,12(5):490-490
<正> 我科于1999—2001年采有耳压方法治疗小儿抽动症患儿57例,效果良好。现将方法介绍如下。1 临床资料1.1 一般资料 本组患儿均符合文献[1]诊断标准。男42例,女15例;年龄最小5岁,最大14岁,5~8岁14例,~11岁26例,~14岁17例;病程最长4年,最短1个月。1.2 治疗方法 以王不留行籽、胶布、有机玻璃板制成0.6 相似文献
8.
Yulu Miao Mingxia Zhang Yulin Nie Wan Zhao Bin Huang Zhengming Jiang Shaoxiong Yu Zhibin Huang Hongjin Fu 《中国神经再生研究》2007,2(2):126-128
BACKGROUND: Besides local changes of cranial parenchymal cells, hemorrhage, etc., severe traumatic brain injuries also cause the changes of total body fluid and various functions, and the changes of lymphocytes and T lymphocyte subsets should be paid more attention to. OBJECTIVE: To reveal the changing laws of T lymphocyte subsets after severe traumatic brain injury, and compare with mild to moderate brain injury. DESIGN: A comparative observation. SETTINGS: Department of Neurosurgery, Longgang District Buji People's Hospital of Shenzhen City; Central Laboratory of Shenzhen Hospital of Prevention and Cure for Chronic Disease. PARTICIPANTS: All the subjects were selected from the Department of Neurosurgery, Longgang District Buji People's Hospital of Shenzhen City from August 2002 to August 2005. Thirty patients with severe brain injury, whose Glasgow coma score (GCS) was ≤ 8 points, were taken as the experimental group, including 21 males and 9 females, aging 16 - 62 years. Meanwhile, 30 patients with mild traumatic brain injury were taken as the control group (GCS ranged 14- 15 points), including 18 males and 12 females, aging 15 -58 years. All the subjects were in admission at 6 hours after injury, without disease of major organs before injury Informed consents were obtained from all the patients or their relatives. METHODS: (1) The T lymphocytes and the subsets in peripheral blood were detected with immunofluorescent tricolor flow cytometry at l, 3, 7 and 14 days after injury in both groups. (2) The conditions of pulmonary infections were observed at 4 days after injury. The differences of measurement data were compared with the t test. MAIN OUTCOME MEASURES: Changes of T lymphocytes subsets at 1 - 14 days after severe and mild or moderate traumatic injury. RESULTS: Finally, 28 and 25 patients with mild to moderate traumatic brain injury, whereas 25 and 21 patients with severe traumatic brain injury were analyzed at 7 and 14 days respectively, and the missed ones died due to the development of disease. (1) Changes of T lymphocyte subsets: At 1 and 3 days after injury, CD3, CD4, CD8, CD4/CD8 began to decrease, whereas CD8 increased in the experimental group, which were very significantly different from those in the control group (t =2.77 - 3.26, P 〈 0.01), and began to recover at 7 days, which were significantly different from those in the control group (t = 2.06 - 2.24, P 〈 0.05), and generally recovered to the normal levels at 14 days (P 〉 0.05). (2) Conditions of pulmonary infections: At 4 days after injury, the rate of pulmonary infection was significantly different between the experimental group and control group [73% (22/30), 0, x2=37.29, P 〈 0.01]. CONCLUSION: Patients with severe traumatic brain injury suffer from damages of cellular immune function at early period (within 7 days), and they are easily to be accompanied by pulmonary infections. 相似文献
9.
BACKGROUND: Researches on diabetic nervous system lesion are mainly focus on peripheral nerve and vegetative nerve, so there are few investigations on diabetic pseudotabes.
OBJECTIVE: To investigate the electrophysiological examinations on the diagnosis of diabetic pseudotabes.
DESIGN: Case study.
SETTING: Department of Electrophysiology and Department of Neurology, Zhongshan Hospital Affiliated to Xiamen University.
PARTICIPANTS: A total of 4 patients with type 2 diabetes mellitus, including 3 males and 1 female aged from 50 to 72 years, were selected from Department of Neurology, Zhongshan Hospital Affiliated to Xiamen University from March 2002 to February 2005. All accepted subjects met the modified diagnostic criteria of diabetes mellitus, which was set by American Diabetes Mellitus Association (ADA) in 1997. Otherwise, the subjects had typical symptoms and physical signs of spinal posterior funiculus damage. However, patients with spinal cord lesion which was caused by other factors were excluded. All accepted subjects provided the confirmed consent.
METHODS: Nicolet NT electromyography (EMG)/evoked potential meter (made in the USA) was used to detect spinal cord conduction velocity (SCCV), somatosensory evoked potential (SEP) of lower limbs, motor nerve conduction velocity (MNCV) and sensory nerve conduction velocity (SNCV) of extremities. Determining criteria: Measurements were performed based on the laboratory standards. SCCV, which was less than lower limit of normal value (T2–12: 40–55 m/s, T12–L4: 20–41 m/s, T2–L4: 36–45 m/s), was regarded as abnormal. SEP value of lower limbs: P40, P60 and PF, which were more than standard deviation of normal value (x(—)+2.5), were regarded as the abnormality. Normal value of P40, P60 and PF latencies (x(—)±s) in this study: P40, P60 and PF in males were (37.6±1.9) ms, (59.8±3.9) ms and (7.6±0.9) ms, respectively; meanwhile, those in females were (35.5±1.7) ms, (55.2±2.7) ms and (6.3±0.7) ms, respectively. MNCV and SNCV, which were less than 50 m/s in upper limbs and 40 m/s in lower limbs, were regarded as the abnormality.
MAIN OUTCOME MEASURES: Electrophysiological examinations.
RESULTS: All 4 patients with type 2 diabetes mellitus were involved in the final analysis. ① SCCV: Among 4 patients, SCCV of three patients was decreased in T2–12, T12–L4 and T2–L4, and that of the other one was decreased in T2–12 and T2–L4; however, SCCV in T12–L4 was normal. There was significant difference as compared with normal value (P < 0.01). ② SEP of lower limbs: SEP values of lower limbs were abnormal in all 4 patients. Among them, P40, P60 and PF latencies of two patients were delayed; P40 of one patient was delayed and PF was not drained out; P40 and P60 of the last one were delayed and PF was normal. ③ MNCV and SNCV: The MNCV and SNCV were normal in one patient and abnormal in three patients. The results demonstrated that MNCV and SNCV of extremities decreased; especially, sensory nerve action potential (SNAP) of both lower extremities of one patient were not drained out.
CONCLUSION: Detections of SCCV, SEP of lower limbs, MNCV and SNCV of extremities are helpful to investigate whether peripheral nerve and deep sensory passage are damaged or not and determine whether deep sensory damage is caused by peripheral nerve and spinal posterior funiculus. 相似文献
10.
目的:研究新疆蒙古族、汉族及内地汉族战士在新疆及内地不同高海拔地区血压的动态变化及民族间差异性。方法:采用上海上达医用仪表厂生产的弹簧式血压计,对新疆蒙古族、汉族及湖北战士在入伍前、入伍后3个月及入伍后18个月,在不同海拔高度地区进行血压测量,进行比较。结果:三地区蒙、汉民族战士血压均在正常范围,收缩压(SBP)、舒张压(DBP)及脉压(PP),呈先下降后上升趋势,仅有湖汉战士组脉压(PP)呈先上升后下降趋势,组内变化有统计学意义,组间对照差异无显著性。结论:无论新疆蒙古族、汉族及内地汉族战士在由平原地区进驻海拔1300m高度服役及训练是安全的,甚至对战士素质提高是有益处的,两民族间对差异无显著性。 相似文献